Prime Capital Investment Advisors, LLC Astrazeneca PLC Transaction History

Prime Capital Investment Advisors, LLC

$6.88 Billion
Q3 2024

A detailed history of Prime Capital Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 22,088 shares of AZN stock, worth $1.44 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

22,088

Previous 24,156 8.56%

Holding current value

$1.44 Million

Previous $1.88 Million 8.6%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$76.67 - $87.62 $158,553 - $181,198	-2,068 Reduced 8.56%	22,088 $1.72 Million
Q2 2024 Aug 08, 2024	SELL	$66.81 - $80.83 $95,404 - $115,425	-1,428 Reduced 5.58%	24,156 $1.88 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $37,838 - $43,133	-620 Reduced 2.37%	25,584 $1.73 Million
Q4 2023 Jan 24, 2024	BUY	$61.89 - $69.28 $625,893 - $700,628	10,113 Added 62.85%	26,204 $1.76 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $6,744 - $7,456	104 Added 0.65%	16,091 $1.09 Million
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $554,176 - $600,945	7,927 Added 98.35%	15,987 $1.14 Million
Q1 2023 May 05, 2023	BUY	$63.15 - $71.6 $182,187 - $206,565	2,885 Added 55.75%	8,060 $559,000
Q4 2022 Feb 08, 2023	BUY	$54.21 - $70.44 $81,477 - $105,871	1,503 Added 40.93%	5,175 $350,000
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $4,559 - $11,674	86 Added 2.4%	3,672 $201,000
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $212,506 - $255,108	3,586 New	3,586 $237,000
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $42,125 - $52,356	-870 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $6,555 - $7,567	-139 Reduced 13.78%	870 $43,000
Q4 2020 Feb 03, 2021	BUY	$48.52 - $58.02 $6,404 - $7,658	132 Added 15.05%	1,009 $50,000
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $106 - $122	2 Added 0.23%	877 $48,000
Q2 2020 Jul 17, 2020	BUY	$43.1 - $55.31 $732 - $940	17 Added 1.98%	875 $46,000
Q1 2020 May 04, 2020	SELL	$37.79 - $51.33 $188 - $256	-5 Reduced 0.58%	858 $38,000
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $4,288 - $5,096	101 Added 13.25%	863 $43,000
Q3 2019 Nov 05, 2019	BUY	$40.12 - $45.47 $30,571 - $34,648	762 New	762 $34,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $119,018 - $136,001	-3,424 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $42,980 - $46,090	1,244 Added 57.06%	3,424 $120,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $69,956 - $75,820	2,180	2,180 $76,000

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

475M

Call Options Held

5.14M

Put Options Held

3.06M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $202B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.

Account

Prime Capital Investment Advisors, LLC Astrazeneca PLC Transaction History